🇺🇸 FDA
Pipeline program

rituximab combined with corticosteroids

HLK-202302

Approved small_molecule active

Quick answer

rituximab combined with corticosteroids for Primary Membranous Nephropathy is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Primary Membranous Nephropathy
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials